Abstract
Approximately 600,000 hysterectomies are performed each year in the United States. Uterine fibroids are the leading indication for this procedure. Some patients choose a more conservative approach. Approximately 81 % of patients who undergo myomectomy have a resolution of their symptoms, but the risk of regrowth of myomas and possible reoperation must be discussed with the patient. Of the almost 40,000 myomectomies performed each year in the United States, only a small fraction are performed in a minimally invasive fashion. The new robotic platform, the da Vinci surgical system (Intuitive Surgical, Inc.; Sunnyvale, CA), was approved by the U.S. Food and Drug Administration in April 2005, allowing the surgeon the advantage of a three-dimensional view of the operative field and the ability to use wristed instruments with 7° of motion, thereby providing a new viable option for patients. This chapter reviews the robotic-assisted laparoscopic myomectomy while providing the most current data.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol. 2002;99:229–34.
Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14:CR24–31.
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–7.
Buttram Jr VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433–45.
Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393–406.
Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynaecol. 1991;98:385–9.
The American Congress of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to Hysterectomy in the Management of Leiomyomas. Obstet Gynecol. 2008;112:387–400.
Semm K, Mettler L. Technical progress in pelvic surgery via operative laparoscopy. Am J Obstet Gynecol. 1980;138:121–5.
Advincula AP, Song A, Burke W, Reynolds RK. Preliminary experience with robot-assisted laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 2004;11:511–8.
Pitter MC, Gargiulo AR, Bonaventura LM, Lehman JS, Srouji SS. Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod. 2013;28:99–108.
Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer. 2002;12:354–61.
Barakat EE, Bedaiwy MA, Zimberg S, Nutter B, Nosseir M, Falcone T. Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117(2 Pt 1):256–65.
Gargiulo AR, Srouji SS, Missmer SA, Correia EF, Velinga T, Einarsson JI. Robot assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy. Obstet Gynecol. 2012;120(2 Pt 1):284–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pitter, M.C. (2014). Robotic-Assisted Laparoscopic Myomectomy. In: Escobar, P., Falcone, T. (eds) Atlas of Single-Port, Laparoscopic, and Robotic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6840-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6840-0_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6839-4
Online ISBN: 978-1-4614-6840-0
eBook Packages: MedicineMedicine (R0)